Though individual markers varied, results collectively supported involvement of the IL-23/Th17/IL-17 axis in the delineation of GWI and CFS in a sex-specific way. The gene discussed is IL17A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.